Khema R Sharma

Professor

  • 2714 Citations
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Khema R Sharma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Medicine & Life Sciences
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Muscle Fatigue Medicine & Life Sciences
Myasthenia Gravis Medicine & Life Sciences
Muscles Medicine & Life Sciences
Duchenne Muscular Dystrophy Medicine & Life Sciences
Fatigue Medicine & Life Sciences
Intravenous Immunoglobulins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 2714 Citations
  • 65 Article
  • 3 Letter
3 Citations (Scopus)

Amifampridine Phosphate (Firdapse) Is Effective in a Confirmatory Phase 3 Clinical Trial in LEMS

Shieh, P., Sharma, K. R., Kohrman, B. & Oh, S. J., Mar 1 2019, In : Journal of clinical neuromuscular disease. 20, 3, p. 111-119 9 p.

Research output: Contribution to journalArticle

Lambert-Eaton Myasthenic Syndrome
Phase III Clinical Trials
Myasthenia Gravis
Placebos
Extremities
2 Citations (Scopus)

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.

Research output: Contribution to journalArticle

Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Safety
Drug-Related Side Effects and Adverse Reactions
13 Citations (Scopus)

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

for the Regain Study Group, Jan 1 2019, In : Muscle and Nerve.

Research output: Contribution to journalArticle

Open Access
Myasthenia Gravis
Safety
Meningococcal Infections
Muscle Strength
Activities of Daily Living
1 Citation (Scopus)
Open Access
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Polyneuropathies
Intravenous Immunoglobulins
Random Allocation
Therapeutics

Intravenous versus subcutaneous immunoglobulin – Authors' reply

PATH study group, May 1 2018, In : The Lancet Neurology. 17, 5, p. 393-394 2 p.

Research output: Contribution to journalLetter

Immunoglobulins